- Home
- FLGC vs SLGL Comparison
FLGC vs SLGL Comparison
Compare FLGC & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- SLGL
- Stock Information
- Founded
- FLGC 2019
- SLGL 1997
- Country
- FLGC United States
- SLGL Israel
- Employees
- FLGC N/A
- SLGL N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- SLGL Health Care
- Exchange
- FLGC Nasdaq
- SLGL Nasdaq
- Market Cap
- FLGC 17.3M
- SLGL 17.0M
- IPO Year
- FLGC 2021
- SLGL 2018
- Fundamental
- Price
- FLGC $0.87
- SLGL $0.58
- Analyst Decision
- FLGC Strong Buy
- SLGL Strong Buy
- Analyst Count
- FLGC 4
- SLGL 2
- Target Price
- FLGC $5.67
- SLGL $5.00
- AVG Volume (30 Days)
- FLGC 276.0K
- SLGL 62.4K
- Earning Date
- FLGC 03-27-2025
- SLGL 03-12-2025
- Dividend Yield
- FLGC N/A
- SLGL N/A
- EPS Growth
- FLGC N/A
- SLGL N/A
- EPS
- FLGC N/A
- SLGL N/A
- Revenue
- FLGC $64,154,000.00
- SLGL $11,707,000.00
- Revenue This Year
- FLGC N/A
- SLGL $772.97
- Revenue Next Year
- FLGC $8.94
- SLGL N/A
- P/E Ratio
- FLGC N/A
- SLGL N/A
- Revenue Growth
- FLGC N/A
- SLGL 869.93
- 52 Week Low
- FLGC $0.72
- SLGL $0.33
- 52 Week High
- FLGC $2.93
- SLGL $1.65
- Technical
- Relative Strength Index (RSI)
- FLGC 45.99
- SLGL 37.73
- Support Level
- FLGC $0.80
- SLGL $0.56
- Resistance Level
- FLGC $0.99
- SLGL $0.61
- Average True Range (ATR)
- FLGC 0.09
- SLGL 0.07
- MACD
- FLGC 0.02
- SLGL -0.01
- Stochastic Oscillator
- FLGC 39.16
- SLGL 12.00
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.